Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-10-18
2005-10-18
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S133100, C424S141100, C424S142100, C424S143100, C424S144100, C424S130100, C530S387100, C530S387300, C530S387900, C530S388100, C530S388220, C530S388750
Reexamination Certificate
active
06955811
ABSTRACT:
Methods and compositions for regulating immunity are disclosed. For enhancing an immune response, agents that inhibit OX-2 are administered. Such methods are useful in treating cancer. For suppressing an immune response, an OX-2 protein or a nucleic acid encoding an OX-2 protein is administered. Such methods are useful in preventing graft rejection, fetal loss, autoimmune disease, allergies and in inducing tumor cell growth.
REFERENCES:
patent: 5434131 (1995-07-01), Linsley et al.
patent: 5916560 (1999-06-01), Larsen et al.
patent: 6338851 (2002-01-01), Gorczynski
patent: WO 97/21450 (1997-06-01), None
patent: WO 99/24565 (1999-05-01), None
Jain Nature Medicine 1998; 4(6):655-657.
Kim et al. Cancer Res. 2001; 61:2031-2037.
Kjaergaard et al. Cancer Res. 2000; 60:5514-5521.
Boon Adv. Cancer Res. 1992; 58:177-210.
Huang Pharmacol. Therapeutics 2000 86:201-215.
Pardoll Clin. Immunol. 2000; 95(1):S44-S62.
Auchincloss, H., Jr. 1995 Transplantation Immunology, 211-218.
Barclay, 1981, Immunology, 44, pp. 727-736.
Barclay and Ward, 1982, European Journal Biochem, 129, pp. 447-458.
Borriello, F. et al., 1998, Mammalian Genome, Feb., 9(2), pp. 114-118.
Borriello, F. et al., 1997, J. Immunol, 158, pp. 4549-4554.
Chen, Z et al., Database Medline, 1997, Biochimica et Biophysica Acta, Nov. 28, 1362(1), pp. 6-10.
Clark DA, Manuel J, Gorczynski RM, Blajchman M. 2001. Labile CD200 tolerance signal important in transfusion-related immunomodulation (TRIM) prevention of recurrent miscarriages. Amer. J. Reprod. Immunol. 45;361.
Gorczynski, R.M. et al., 1998, Transplantation, Apr. 27, 65(8), pp. 1106-1114.
Gorczynski, R.M. et al., 1999, J. Immunol, 163:1654-1660.
Preston, S. et al., 1997, European Journal of Immunology, vol. 27, No. 8, pp. 1911-1918.
Ni, J., et al. “An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant which prolongs allograft survival”, FASEB Journal, vol. 13, No. 5, p. A983 (1999).
Ragheb, R. et al., “Preparation and functional properties of monoclonal antibodies to human, mouse and rat OX-2”, Immunology Letters, vol. 68, No. 2-3, p. 311-315 (1999).
Clark David A.
Gorczynski Reginald M.
Gambel Phillip
Ouspenski Ilia
Trillium Therapeutics Inc.
LandOfFree
Methods of inhibiting immune response suppression by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting immune response suppression by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting immune response suppression by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3463483